Skip to content

Postoperative Acute Myocardial Ischemic Injury

Detection and Prediction of Postoperative Acute Myocardial Ischemic Injury/Infarction by the VectraplexECG System With CEB®

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02993263
Enrollment
323
Registered
2016-12-15
Start date
2016-02-29
Completion date
2018-12-31
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Brief summary

The investigators propose to estimate the sensitivity and specificity of the VectraplexECG System for detecting acute myocardial ischemic injury, including acute myocardial infarctions after major non-cardiac surgery. A 10 second CEB dynamic sequence recording will be obtained immediately after surgery in the post-anesthesia care unit. On the first, second and third post operative morning a 10 second CEB dynamic sequence will be recorded. Blood will be sampled for troponin as well. On the first, second and third post operative afternoons a 10 second CEB dynamic sequence will be recorded. The morning 10 second CEB dynamic sequence and blood draw for troponin will continue as long as the patient remains hospitalized. The afternoon 10 second CEB dynamic sequence will continue as long as the patient remains hospitalized.

Interventions

DEVICEVectraplexECG System with CEB®

The device will be used after noncardiac surgery

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Written informed consent. 2. ≥ 45 years old. 3. Anticipated hospitalization of at least two nights.

Exclusion criteria

1. Inadequate ECGs, based on an initial 10-second trace, as defined by: * wandering baseline * excessive noise * ventricular ectopy * pacer spikes or * lead placement error 2. Atrial fibrillation. 3. Average heart rate exceeding 90 beats/minute. 4. Evidence of previous myocardial infarction: * Pathologic Q waves (≥0.04 sec) and/or * Pathologic findings of a healed or healing MI and/or * Evidence from an imaging study of a region of loss of viable myocardium

Design outcomes

Primary

MeasureTime frameDescription
Accuracy1 minute to complete the testAccuracy of VectraplexECG System with CEB

Countries

United States

Participant flow

Recruitment details

Recruitment process started by screening patients who are scheduled for non cardiac surgery. These patients are approached during their anesthesia clearance visit.

Pre-assignment details

Open label study

Participants by arm

ArmCount
Noncardiac Surgery
VectraplexECG System with CEB® used after surgery and on day 1, 2, and 3 postoperatively
323
Total323

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyEquipment Software failed and results were lost.323

Baseline characteristics

CharacteristicNoncardiac Surgery
Age, Continuous62.9 years
STANDARD_DEVIATION 9.3
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
164 Participants
Sex: Female, Male
Male
159 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Accuracy

Accuracy of VectraplexECG System with CEB

Time frame: 1 minute to complete the test

Population: Data were not collected, because of the malfunction of the equipment software failed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026